Pediatric suspension formulation
The present disclosure relates to storage-stable proton pump inhibitor (PPI) systems comprising a therapeutically effective amount of a PPI or a pharmaceutically acceptable salt thereof, such as omeprazole or a pharmaceutically acceptable salt thereof, which are constituted with water prior to admin...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
07.04.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present disclosure relates to storage-stable proton pump inhibitor (PPI) systems comprising a therapeutically effective amount of a PPI or a pharmaceutically acceptable salt thereof, such as omeprazole or a pharmaceutically acceptable salt thereof, which are constituted with water prior to administration. The present disclosure also relates to oral pharmaceutical suspensions comprising water, a therapeutically effective amount of a PPI or a pharmaceutically acceptable salt thereof, such as omeprazole or a pharmaceutically acceptable salt thereof, and one or more buffering agents. |
---|---|
AbstractList | The present disclosure relates to storage-stable proton pump inhibitor (PPI) systems comprising a therapeutically effective amount of a PPI or a pharmaceutically acceptable salt thereof, such as omeprazole or a pharmaceutically acceptable salt thereof, which are constituted with water prior to administration. The present disclosure also relates to oral pharmaceutical suspensions comprising water, a therapeutically effective amount of a PPI or a pharmaceutically acceptable salt thereof, such as omeprazole or a pharmaceutically acceptable salt thereof, and one or more buffering agents. |
Author | CLANCY, Maurice Joseph Anthony FLYNN, Damien Patrick MCDAID, Dennis Mark |
Author_xml | – fullname: CLANCY, Maurice Joseph Anthony – fullname: MCDAID, Dennis Mark – fullname: FLYNN, Damien Patrick |
BookMark | eNrjYmDJy89L5WRQCEhNyUwsKcpMViguLS5IzSvOzM9TSMsvyi3NSSwBsnkYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSbxjqJGBkYGxqYWJuZGjoTFxqgAJrihz |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | AU2020358472A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_AU2020358472A13 |
IEDL.DBID | EVB |
IngestDate | Fri Sep 20 10:13:41 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_AU2020358472A13 |
Notes | Application Number: AU20200358472 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220407&DB=EPODOC&CC=AU&NR=2020358472A1 |
ParticipantIDs | epo_espacenet_AU2020358472A1 |
PublicationCentury | 2000 |
PublicationDate | 20220407 |
PublicationDateYYYYMMDD | 2022-04-07 |
PublicationDate_xml | – month: 04 year: 2022 text: 20220407 day: 07 |
PublicationDecade | 2020 |
PublicationYear | 2022 |
RelatedCompanies | XEOLAS PHARMACEUTICALS LTD |
RelatedCompanies_xml | – name: XEOLAS PHARMACEUTICALS LTD |
Score | 3.3885443 |
Snippet | The present disclosure relates to storage-stable proton pump inhibitor (PPI) systems comprising a therapeutically effective amount of a PPI or a... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BABY COMFORTERS CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICALPURPOSES DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY DEVICES FOR RECEIVING SPITTLE DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGINGPHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL ORADMINISTERING FORMS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Pediatric suspension formulation |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220407&DB=EPODOC&locale=&CC=AU&NR=2020358472A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTIEtgHM0tJ0U9PSUkBXmBnoWiZbpuqmWJgnJaUkmZqnJoIG9H39zDxCTbwiTCOYGHJge2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGrR3bGQETJPmai5Otq4B_i7-zmrOzsCepJpfEEjOwBg0JWjkCOwrsYIa0qCT9l3DnED7UgqQKxU3QQa2AKB5eSVCDEypecIMnM6wu9eEGTh8oVPeQCY09xWLMCjA79VQKC4tLgAtPc_PUwC1OqF3cIkyKLu5hjh76AKtiof7LN4xFNldxmIMLMA-f6oEg0KycaJJmrlRoiWo15hoAYzuNBOTNMvklBQj0zRgWSnJIIPPJCn80tIMXKCwAi9AMZdhYCkpKk2VBdatJUly4CABAFNEfgs |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTIEtgHM0tJ0U9PSUkBXmBnoWiZbpuqmWJgnJaUkmZqnJoIG9H39zDxCTbwiTCOYGHJge2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGrR3bGQETJPmai5Otq4B_i7-zmrOzsCepJpfEEjOwBg0JWjkCOwrsZqDzucFNZ7CnED7UgqQKxU3QQa2AKB5eSVCDEypecIMnM6wu9eEGTh8oVPeQCY09xWLMCjA79VQKC4tLgAtPc_PUwC1OqF3cIkyKLu5hjh76AKtiof7LN4xFNldxmIMLMA-f6oEg0KycaJJmrlRoiWo15hoAYzuNBOTNMvklBQj0zRgWSnJIIPPJCn80vIMnB4hvj7xPp5-3tIMXKBwAy9GMZdhYCkpKk2VBdazJUly4OABAGBkgPg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Pediatric+suspension+formulation&rft.inventor=CLANCY%2C+Maurice+Joseph+Anthony&rft.inventor=MCDAID%2C+Dennis+Mark&rft.inventor=FLYNN%2C+Damien+Patrick&rft.date=2022-04-07&rft.externalDBID=A1&rft.externalDocID=AU2020358472A1 |